Clinical Islet Xenotransplantation

Type 1 diabetes (T1D) is a major health problem throughout the world. In the U.S., it is estimated that about 1.5 million people suffer from T1D. Even when well controlled—by frequent monitoring of blood glucose and administration of insulin, the long-term complications of the disease are significant and include cardiovascular disease, nephropathy, retinopathy, and neuropathy (1). Here we review recent progress in preclinical models of pig islet xenotransplantation and discuss the remaining challenges that need to be addressed before the application of this form of therapy can be established in patients with T1D. During the past decade, islet allotransplantation alone (without previous kidney transplantation) using deceased human donor pancreata has been indicated mainly in patients who have had T1D for >5 years with life-threatening hypoglycemic episodes and wide fluctuations in blood glucose levels. Although the initial long-term results were rather disappointing (2), the results of islet allotransplantation have improved significantly in recent years, with 5-year insulin-independent normoglycemia achieved in >50% of patients at experienced centers (3). There is increasing evidence that successful islet allotransplantation greatly reduces the incidence of hypoglycemic episodes (2) and reduces or slows the incidence of late complications of T1D (4). This may extend the indications for islet transplantation to patients with progressive complications. For example, islet transplantation in a patient with preterminal renal failure may prevent disease progression, possibly avoiding the need for hemodialysis and kidney transplantation, provided that nonnephrotoxic immunosuppressive drug therapy is administered. Currently, in the U.S., the median waiting time for a kidney allograft from a deceased human donor is >4 years (5). However, islets from two deceased human donor pancreata are frequently required to achieve normoglycemia in a diabetic patient. Because of the limited number of suitable deceased donor pancreata, the overall number of …

[1]  K. Haruma,et al.  Technique of Endoscopic Biopsy of Islet Allografts Transplanted into the Gastric Submucosal Space in Pigs , 2013, Cell transplantation.

[2]  R. Bottino,et al.  Early Islet Damage after Direct Exposure of Pig Islets to Blood: Has Humoral Immunity Been Underestimated? , 2012, Cell transplantation.

[3]  A. Kirk,et al.  Islet Xenotransplantation Using Gal‐Deficient Neonatal Donors Improves Engraftment and Function , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  L. Scobie,et al.  Xenotransplantation of galactosyl-transferase knockout, CD55, CD59, CD39, and fucosyl-transferase transgenic pig kidneys into baboons. , 2011, Transplantation proceedings.

[5]  B. Hering,et al.  Species incompatibilities in the pig‐to‐macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation , 2011, Xenotransplantation.

[6]  C. Ricordi,et al.  Donor Islet Endothelial Cells in Pancreatic Islet Revascularization , 2011, Diabetes.

[7]  A. Shapiro,et al.  State of the Art of Clinical Islet Transplantation and Novel Protocols of Immunosuppression , 2011, Current diabetes reports.

[8]  G. Korbutt,et al.  CD40‐Specific Costimulation Blockade Enhances Neonatal Porcine Islet Survival in Nonhuman Primates , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  W. Hawthorne,et al.  The Importance of Tissue Factor Expression by Porcine NICC in Triggering IBMIR in the Xenograft Setting , 2011, Transplantation.

[10]  R. Elliott.  Towards xenotransplantation of pig islets in the clinic. , 2011, Current opinion in organ transplantation.

[11]  N. Mueller,et al.  Microbial safety in xenotransplantation , 2011, Current opinion in organ transplantation.

[12]  M. Murtaugh,et al.  Microbiological safety of porcine islets: comparison with source pig , 2011, Xenotransplantation.

[13]  G. Warnock,et al.  Reduced Progression of Diabetic Microvascular Complications With Islet Cell Transplantation Compared With Intensive Medical Therapy , 2011, Transplantation.

[14]  Denis Dufrane,et al.  Alginate Macroencapsulation of Pig Islets Allows Correction of Streptozotocin-Induced Diabetes in Primates up to 6 Months Without Immunosuppression , 2010, Transplantation.

[15]  J. Ijzermans,et al.  Investigation of Lymphocyte Depletion and Repopulation Using Alemtuzumab (Campath‐1H) in Cynomolgus Monkeys , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  R. Bottino,et al.  Insulin secretion and glucose metabolism in alpha 1,3‐galactosyltransferase knock‐out pigs compared to wild‐type pigs , 2010, Xenotransplantation.

[17]  H. Niemann,et al.  Generation and characterization of pigs transgenic for human hemeoxygenase‐1 (hHO‐1) , 2010 .

[18]  D. Raleigh,et al.  Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts , 2010, Proceedings of the National Academy of Sciences.

[19]  R. Bottino,et al.  Long‐Term Controlled Normoglycemia in Diabetic Non‐Human Primates After Transplantation with hCD46 Transgenic Porcine Islets , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  M. Trucco,et al.  Endoscopic Gastric Submucosal Transplantation of Islets (ENDO‐STI): Technique and Initial Results in Diabetic Pigs , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  H. Niemann,et al.  Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli , 2009, Xenotransplantation.

[22]  H. Niemann,et al.  Pigs transgenic for human thrombomodulin have elevated production of activated protein C , 2009, Xenotransplantation.

[23]  M. Mendicino,et al.  Production and characterization of transgenic pigs expressing porcine CTLA4‐Ig , 2009, Xenotransplantation.

[24]  C. Mathieu,et al.  Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients , 2009, Diabetes.

[25]  A. Tobar,et al.  Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model , 2009, Proceedings of the National Academy of Sciences.

[26]  Suganya Srinivasan,et al.  Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. , 2009, Journal of autoimmunity.

[27]  D. Cooper,et al.  Global Consultation on Regulatory Requirements for Xenotransplantation in Clinical Trials , 2009, Xenotransplantation.

[28]  R. Wanke,et al.  HLA-E/Human &bgr;2-Microglobulin Transgenic Pigs: Protection Against Xenogeneic Human Anti-Pig Natural Killer Cell Cytotoxicity , 2009, Transplantation.

[29]  P. Chaffanjon,et al.  Long‐Term Survival of Nonhuman Primate Islets Implanted in an Omental Pouch on a Biodegradable Scaffold , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  H. Tai,et al.  In vitro investigation of pig cells for resistance to human antibody‐mediated rejection , 2008, Transplant international : official journal of the European Society for Organ Transplantation.

[31]  H. Waldmann,et al.  Fc‐Disabled Anti‐Mouse CD40L Antibodies Retain Efficacy in Promoting Transplantation Tolerance , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[32]  John D Lambris,et al.  Dissecting the instant blood‐mediated inflammatory reaction in islet xenotransplantation , 2008, Xenotransplantation.

[33]  G. Korbutt,et al.  Sertoli Cell Line Lacks the Immunoprotective Properties Associated with Primary Sertoli Cells , 2008, Cell transplantation.

[34]  R. Kurth,et al.  Knockdown of porcine endogenous retrovirus (PERV) expression by PERV‐specific shRNA in transgenic pigs , 2008, Xenotransplantation.

[35]  B. Hering,et al.  Engraftment of Adult Porcine Islet Xenografts in Diabetic Nonhuman Primates Through Targeting of Costimulation Pathways , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[36]  M. Fisher,et al.  Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) , 2007 .

[37]  R. Bottino,et al.  Isolation outcome and functional characteristics of young and adult pig pancreatic islets for transplantation studies , 2007, Xenotransplantation.

[38]  G. Korbutt,et al.  Neonatal Porcine Islets Exhibit Natural Resistance to Hypoxia-Induced Apoptosis , 2006, Transplantation.

[39]  K. Polonsky,et al.  A Significant Role for Histocompatibility in Human Islet Transplantation , 2006, Transplantation.

[40]  U. Christians,et al.  Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates , 2006, Nature Medicine.

[41]  G. Korbutt,et al.  Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways , 2006, Nature Medicine.

[42]  B. Zinman,et al.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.

[43]  Eduardo Bracho-Blanchet,et al.  Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. , 2005, European journal of endocrinology.

[44]  K. Ekdahl,et al.  Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. , 2005 .

[45]  B. Loveland,et al.  Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non‐immunosuppressed baboons , 2004, Xenotransplantation.

[46]  S. Saidman,et al.  Alloantibody and xenoantibody cross-reactivity in transplantation. , 2004, Transplantation.

[47]  K. Ekdahl,et al.  Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation , 2002, The Lancet.

[48]  S. H. A. Chen,et al.  Production of α1,3-Galactosyltransferase-Deficient Pigs , 2002, Science.

[49]  K. Ekdahl,et al.  Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. , 2002, Diabetes.

[50]  P. Carlsson,et al.  Graft vascular function after transplantation of pancreatic islets , 2002, Diabetologia.

[51]  L. Copeman,et al.  Production and characterization of a pig line transgenic for human membrane cofactor protein , 2002, Xenotransplantation.

[52]  T. Starzl,et al.  Molecular Basis of Evolutionary Loss of the α1,3-Galactosyltransferase Gene in Higher Primates* , 2002, The Journal of Biological Chemistry.

[53]  Yifan Dai,et al.  Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs , 2002, Nature Biotechnology.

[54]  T. Shigehisa,et al.  Remodeling of the Major Pig Xenoantigen by N-Acetylglucosaminyltransferase III in Transgenic Pig* , 2001, The Journal of Biological Chemistry.

[55]  G. Elgue,et al.  Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. , 2000, Transplantation.

[56]  R. Colvin,et al.  Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand , 2000, Nature Medicine.

[57]  G. Korbutt,et al.  Neonatal porcine islet cells induce human CD4+, but not CD8+, lymphocyte proliferation and resist cell-mediated cytolytic injury in vitro. , 1999, Diabetes.

[58]  A. Sun,et al.  Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. , 1996, The Journal of clinical investigation.

[59]  G. Korbutt,et al.  Large scale isolation, growth, and function of porcine neonatal islet cells. , 1996, The Journal of clinical investigation.

[60]  J. Platt,et al.  Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. , 1996, Transplantation.

[61]  N. London,et al.  Transplantation of porcine fetal pancreas to diabetic patients , 1995, The Lancet.

[62]  D. Cooper,et al.  Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. , 1992, Transplantation proceedings.

[63]  J. Tollemar,et al.  Transplantation of porcine fetal pancreas to a diabetic patient. , 1992, Transplantation proceedings.

[64]  I. Campbell,et al.  Reactivity to Human Islets and Fetal Pig Proislets by Peripheral Blood Mononuclear Cells From Subjects With Preclinical and Clinical Insulin-Dependent Diabetes , 1991, Diabetes.

[65]  A. Varki,et al.  Potential impact of the non‐human sialic acid N‐glycolylneuraminic acid on transplant rejection risk , 2011, Xenotransplantation.

[66]  First WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials Changsha, China, 19–21 November 2008 , 2009, Xenotransplantation.

[67]  R. Pierson,et al.  The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-- executive summary. , 2009, Xenotransplantation.

[68]  R. Bottino,et al.  Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice , 2007, Diabetologia.

[69]  T. Starzl,et al.  Production of alpha 1,3-galactosyltransferase-deficient pigs. , 2003, Science.

[70]  B. Hering,et al.  In vitro and in vivo expression of Gal (cid:1) –(1,3)Gal on porcine islet cells is age dependent , 2003 .

[71]  Yifan Dai,et al.  Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. , 2002, Nature biotechnology.

[72]  T. Starzl,et al.  Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. , 2002, The Journal of biological chemistry.

[73]  D. White,et al.  Production of pigs transgenic for human DAF to overcome complement-mediated hyperacute xenograft rejection in man. , 1996, Research in immunology.

[74]  Wm. Stowe Devol.  Sixth Annual Report , 1895 .